Tyrosine‐derived polycarbonates: Backbone‐modified “pseudo”‐poly(amino acids) designed for biomedical applications

Abstract

Starting from L‐tyrosine (Tyr) and its metabolites desaminotyrosine (Dat) and tyramine (Tym), four structurally related model dipeptides were prepared: Dat‐Tym (neither N‐ or C‐terminus present), Z‐Tyr‐Tym (N‐terminus protected by benzyloxycarbonyl), Dat‐Tyr‐Hex (C‐terminus protected by a hexyl ester group), and Z‐Tyr‐Tyr‐Hex (both N‐ and C‐termini present, protected by benzyloxycarbonyl and hexyl ester, respectively). The model dipeptides were used as monomers in the synthesis of polycarbonates. The polymerization reaction in the presence of either phosgene or triphosgene proceeded via the phenolic hydroxyl groups. Polymers with molecular weights of 105,000–400,000 da (by gel permeation chromatography, relative to polystyrene standards) were obtained. The physicomechanical properties (solubility, mechanical strength, glass transition and decomposition temperature, processibility) of the polymers were determined, and an attempt was made to correlate the polymer properties with the nature of the N‐ and C‐terminus protecting groups. The presence of the urethane bond at the N‐terminus protecting group was found to reduce solubility, ductility, and processibility, probably due to interchain hydrogen bonding. The presence of a C‐terminus alkyl ester group increased solubility and processibility. Thus, the most promising candidate polymer for biomedical applications was obtained from Dat‐Tyr‐Hex, the monomer carrying a C‐terminus protecting group only. Since very similar results had recently been obtained for a series of structurally related polyiminocarbonates, the structure property correlations seem to be generally valid.